In markets where there is state/PMI reimbursement of GLP-1 treatment for obesity (eg the US), retatrutide is likely to be reserved as a second-line GLP-1 for those who have failed to lose sufficient weight with a cheaper alternative (such as semaglutide or tirzepatide)
Some of the more common peptide therapies There are many different types of peptide therapies on the market today
At this time, patients should not panic, but they should be informed
This mimics normal physiology and avoids disrupting hormone feedback loops
doi: 10.3389/fimmu.2014.00461 137 KawasakiK.KondohE.ChigusaY.KawamuraY.MogamiH.TakedaS.et al
[105] [102] [106] Several other applications to sell generic versions have been made, but not yet approved, including by Aspen Pharmacare, Sandoz, Taro Pharmaceuticals and Teva Pharmaceuticals